FDA approves first generic version of EpiPen
On Thursday, the Food and Drug Administration approved the first generic version of the EpiPen, used to treat severe allergic reactions to everything from food to insect bites.
Teva Pharmaceuticals is now authorized to sell the generic versions of EpiPen and Epi Pen Jr., made by Mylan. "This approval means patients living with severe allergies who require constant access to life-saving epinephrine should have a lower-cost option, as well as another approved product to help protect against potential shortages," FDA Commissioner Scott Gottlieb said in a statement.
EpiPen is the most widely prescribed epinephrine auto-injector in the U.S. Mylan has come under fire for charging as much as $600 for a package of two pens. Teva has not said how much its generic version will cost.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Can Mike Johnson keep his job?Today's Big Question GOP women come after the House leader
-
A postapocalyptic trip to Sin City, a peek inside Taylor Swift’s “Eras” tour, and an explicit hockey romance in December TVthe week recommends This month’s new television releases include ‘Fallout,’ ‘Taylor Swift: The End Of An Era’ and ‘Heated Rivalry’
-
‘These accounts clearly are designed as a capitalist alternative’Instant Opinion Opinion, comment and editorials of the day
-
US mints final penny after 232-year runSpeed Read Production of the one-cent coin has ended
-
Warner Bros. explores sale amid Paramount bidsSpeed Read The media giant, home to HBO and DC Studios, has received interest from multiple buying parties
-
Gold tops $4K per ounce, signaling financial uneaseSpeed Read Investors are worried about President Donald Trump’s trade war
-
Electronic Arts to go private in record $55B dealspeed read The video game giant is behind ‘The Sims’ and ‘Madden NFL’
-
New York court tosses Trump's $500M fraud fineSpeed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in IntelSpeed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to ChinaSpeed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with DisneySpeed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
